CERRITO, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 10.064
EU - Europa 4.768
AS - Asia 4.584
SA - Sud America 661
Continente sconosciuto - Info sul continente non disponibili 634
AF - Africa 105
OC - Oceania 9
Totale 20.825
Nazione #
US - Stati Uniti d'America 9.634
SG - Singapore 1.624
IT - Italia 1.463
CN - Cina 1.203
DE - Germania 950
BR - Brasile 504
HK - Hong Kong 487
RU - Federazione Russa 485
VN - Vietnam 461
SE - Svezia 368
CA - Canada 344
IE - Irlanda 302
GB - Regno Unito 295
UA - Ucraina 191
FR - Francia 189
IN - India 172
FI - Finlandia 105
ID - Indonesia 98
AT - Austria 89
KR - Corea 82
DK - Danimarca 78
TR - Turchia 75
BD - Bangladesh 71
AR - Argentina 56
NL - Olanda 54
JP - Giappone 52
IQ - Iraq 51
MX - Messico 40
ZA - Sudafrica 39
PL - Polonia 37
BE - Belgio 32
PK - Pakistan 31
SA - Arabia Saudita 30
VE - Venezuela 25
ES - Italia 24
CH - Svizzera 22
CO - Colombia 21
PH - Filippine 21
EC - Ecuador 20
UZ - Uzbekistan 20
LT - Lituania 18
CL - Cile 15
CZ - Repubblica Ceca 13
KE - Kenya 13
MA - Marocco 13
IR - Iran 11
MY - Malesia 11
EU - Europa 9
JM - Giamaica 9
JO - Giordania 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
LB - Libano 8
AL - Albania 7
HU - Ungheria 7
NP - Nepal 7
PS - Palestinian Territory 7
RS - Serbia 7
EG - Egitto 6
ET - Etiopia 6
KZ - Kazakistan 6
NI - Nicaragua 6
TH - Thailandia 6
TN - Tunisia 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
PE - Perù 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BB - Barbados 4
BG - Bulgaria 4
BY - Bielorussia 4
HN - Honduras 4
MU - Mauritius 4
NO - Norvegia 4
TW - Taiwan 4
OM - Oman 3
PR - Porto Rico 3
SN - Senegal 3
SV - El Salvador 3
AG - Antigua e Barbuda 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 20.180
Città #
Ann Arbor 1.818
Ashburn 1.041
Singapore 1.006
San Jose 755
Frankfurt am Main 632
Milan 615
Hong Kong 462
Chandler 356
Wilmington 355
Fairfield 348
Woodbridge 295
Dublin 293
Houston 276
Beijing 261
New York 234
Los Angeles 197
Council Bluffs 193
Toronto 187
Dearborn 186
Jacksonville 183
Santa Clara 150
Seattle 147
Dallas 145
Ho Chi Minh City 142
Cambridge 121
Hefei 120
Chicago 118
Hangzhou 110
Hanoi 102
Princeton 95
The Dalles 93
Boardman 82
Shanghai 82
Columbus 78
Jakarta 77
Seoul 73
Vienna 73
Munich 68
Rome 60
Buffalo 59
Nanjing 58
São Paulo 55
Lauterbourg 53
Helsinki 46
Moscow 45
Kent 42
Altamura 41
Tokyo 39
Lawrence 38
Phoenix 38
Orem 37
London 36
Guangzhou 35
Ottawa 34
Brooklyn 32
Denver 32
Warsaw 32
Atlanta 31
Montreal 31
Lachine 30
San Diego 30
Brussels 27
Fremont 26
Mumbai 26
Nanchang 25
Lissone 24
Shenyang 23
Chennai 20
Desio 20
Stockholm 19
Tashkent 19
Amsterdam 18
Haiphong 18
Porto Alegre 18
Turin 18
Dhaka 17
Dong Ket 17
Johannesburg 17
Nuremberg 17
Paris 17
Rio de Janeiro 17
Turku 17
Washington 17
Baghdad 16
Mexico City 16
Poplar 16
Zhengzhou 16
Jinan 15
Manchester 15
Monza 15
Pune 15
Ankara 14
Boston 14
Changsha 14
Da Nang 14
San Francisco 14
Zurich 14
Andover 13
Edmonton 13
Kunming 13
Totale 13.187
Nome #
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 672
BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers 636
Magnetic tweezers measurements of the nanomechanical stability of DNA against denaturation at various conditions of pH and ionic strength 633
Combinations of a btk inhibitor and fluorouracil for treating cancers 593
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype 591
Pharmaceutical kit for use in the treatment of colon and colorectal cancer 554
GSK3A Is Redundant with GSK3B in Modulating Drug Resistance and Chemotherapy-Induced Necroptosis 539
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 518
Platinum-Based Drugs and DNA Interactions Studied by Single-Molecule and Bulk Measurements 498
Biliverdin Protects against Liver Ischemia Reperfusion Injury in Swine 473
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 472
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 458
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 455
CMV-based episomal vector is progressively lost in vivo in multi-gene transgenic pigs produced by SMGT 437
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 433
Does additional coronary artery bypass grafting to aortic valve replacement in elderly patients affect the early and long-term outcome? 421
Pathogenetic role of hypercholesterolemia in a novel preclinical model of vascular injury in pigs 402
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer 393
Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients 393
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 382
Diet Induced Mild Hypercholesterolemia in Pigs: Local and Systemic Inflammation, Effects on Vascular Injury - Rescue by High-Dose Statin Treatment 377
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 371
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 370
Evaluation of systemic and tissue-specific inflammation as risk factor for atherosclerosis in pigs fed with high-fat diet 362
Sperm-mediated gene transfer 358
In vitro production of multigene transgenic blastocysts via sperm-mediated gene transfer allows rapid screening of constructs to be used in xenotransplantation experiments 358
Genetically modified pigs produced with a nonviral episomal vector 354
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 351
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 337
p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors 335
Heme oxygenase-1 inhibition prevents intimal hyperplasia enhancing nitric oxide-dependent apoptosis of vascular smooth muscle cells 334
Mild-hypercholesterolemia exacerbates intimal hyperplasia after vascular injury by suppressing heme oxygenase-1 expression 328
Simultaneous over-expression of graft protective hHO-1, hCD73 and hCD39: effects against cell cytotoxicity and cell death induced by the inflammatory cytokine TNF-α in an in vitro model 328
Minimal Extracorporeal Circulation and Minimally Invasive Valve Operations: Should They Be the Right Combination in the Future? 327
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 326
Sperm-Mediated Genetic Modifications 312
The antiangiogenic effect of the metronomic combination of 5-Fluorouracil plus vinorelbine is mediated by FAK/AKT pathway downregulation and apoptosis activation 310
Heme oxygenase-1 and nitric oxide in the vasculature: in vivo balloon injury and in vitro VSMC studies in rats 292
Production of multi-gene transgenic pigs by sperm-mediated gene transfer for xenotransplantation 291
Infusion of escherichia coli lipopolysaccharide toxin in rats produces an early and severe impairment of baroreflex function in absence of blood pressure changes 289
Simultaneous expression of novel combinations of graft protective human genes in porcine endothelial cells 289
Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5′-nucleotidase in pig endothelial cells 289
Statins Reduce Vascular Injury in a Preclinical and Clinical Model of Arteriosclerosis 275
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 273
Emerging actionable targets to treat therapy-resistant colorectal cancers 273
Identifying novel actionable targets in colon cancer 268
Role of nitric oxide and heme oxygenase-1 in the prevention of intimal hyperplasia development 255
Molecular therapy as a new strategy in the prevention of restenosis. Role of NO/iNOS and CO/HO-1 in inhibition of intimal hyperplasia in a rodent model of balloon injury 248
Methods for sperm-mediated gene transfer 248
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 234
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 231
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 225
An Olive Oil Mill Wastewater Extract Improves Chemotherapeutic Activity Against Breast Cancer Cells While Protecting From Cardiotoxicity 225
Metronomic chemotherapy 211
BTK, the new kid on the (oncology) block? 196
"Ironing out" fasting-induced persister cancer cells to render chemotherapy effective: is this the solution? 186
Targeting p65BTK for treating solid cancers 167
Metronomic 5-Fluorouracil and Vinorelbine Reduce Cancer Stemness and Modulate EZH2/NOTCH-1/STAT3 Signaling in Triple-Negative Breast Cancer Spheroids 69
Totale 20.825
Categoria #
all - tutte 63.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022535 0 0 0 76 35 45 52 25 33 46 91 132
2022/20231.757 165 469 158 189 127 228 68 85 92 64 58 54
2023/20241.268 77 66 69 121 112 278 232 63 48 29 33 140
2024/20252.704 145 258 212 136 208 137 177 100 263 433 238 397
2025/20267.199 823 398 536 805 979 351 1.206 268 536 623 320 354
2026/20271.283 192 320 599 172 0 0 0 0 0 0 0 0
Totale 20.825